SIGLEC1 and infection: The angiotensin-converting enzyme-2 (ACE-2) is a receptor for SARS-CoV-2, while surface lectins such as CD169 (also known as SIGLEC1) enhance ACE-2-dependent infection (Lempp et al., 2021; Li et al., 2003).